1. Home
  2. QGEN vs COKE Comparison

QGEN vs COKE Comparison

Compare QGEN & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QGEN
  • COKE
  • Stock Information
  • Founded
  • QGEN 1986
  • COKE 1902
  • Country
  • QGEN Netherlands
  • COKE United States
  • Employees
  • QGEN N/A
  • COKE N/A
  • Industry
  • QGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • COKE Beverages (Production/Distribution)
  • Sector
  • QGEN Health Care
  • COKE Consumer Staples
  • Exchange
  • QGEN Nasdaq
  • COKE Nasdaq
  • Market Cap
  • QGEN 9.9B
  • COKE 11.7B
  • IPO Year
  • QGEN 1996
  • COKE N/A
  • Fundamental
  • Price
  • QGEN $39.51
  • COKE $1,388.79
  • Analyst Decision
  • QGEN Buy
  • COKE
  • Analyst Count
  • QGEN 8
  • COKE 0
  • Target Price
  • QGEN $49.79
  • COKE N/A
  • AVG Volume (30 Days)
  • QGEN 1.1M
  • COKE 51.5K
  • Earning Date
  • QGEN 04-28-2025
  • COKE 05-05-2025
  • Dividend Yield
  • QGEN 3.29%
  • COKE 0.72%
  • EPS Growth
  • QGEN N/A
  • COKE 60.86
  • EPS
  • QGEN 0.38
  • COKE 69.94
  • Revenue
  • QGEN $1,978,214,000.00
  • COKE $6,899,716,000.00
  • Revenue This Year
  • QGEN $5.15
  • COKE N/A
  • Revenue Next Year
  • QGEN $6.49
  • COKE N/A
  • P/E Ratio
  • QGEN $105.49
  • COKE $19.30
  • Revenue Growth
  • QGEN 0.66
  • COKE 3.69
  • 52 Week Low
  • QGEN $37.63
  • COKE $800.76
  • 52 Week High
  • QGEN $47.93
  • COKE $1,460.92
  • Technical
  • Relative Strength Index (RSI)
  • QGEN 46.28
  • COKE 60.05
  • Support Level
  • QGEN $39.31
  • COKE $1,268.23
  • Resistance Level
  • QGEN $40.27
  • COKE $1,334.48
  • Average True Range (ATR)
  • QGEN 0.55
  • COKE 33.60
  • MACD
  • QGEN 0.16
  • COKE 8.27
  • Stochastic Oscillator
  • QGEN 50.00
  • COKE 99.93

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).

About COKE Coca-Cola Consolidated Inc.

Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.

Share on Social Networks: